ClinicalTrials.gov
public full text
Public Domain
Discontinuation of Levothyroxine Therapy for Patients With Subclinical Hypothyroidism
The investigators propose the following hypothesis: discontinuation of levothyroxine (LT4) for veterans with subclinical hypothyroidism (SCH) will be feasible, acceptable, and safe and will not negatively affect their Quality of Life (QoL). The investigators aim to evaluate the feasibility of LT4 discontinuation among veterans with SCH and determine the changes in QoL measures, lipids, and adverse events.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Long-Term Efficacy and Safety of Once-Weekly Levothyroxine Regimen in Hypothyroid Patients#905257
- Discontinuation of Low-Dose Levothyroxine in Older Adults With Subclinical Hypothyroidism#890189
- Levothyroxine Supplementation for Heart Transplant Recipients#813922
- Comparison Between Variable Time Regimen of Dosing L-Thyroxine for Treatment Hypothyroid Fasting Ramadan#895167
- Thyroid V40 as a potential early predictor of hypothyroidism following hypofractionated locoregional breast radiotherapy#292683
Record · ID 1114710
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive